MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$7,845K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of inve...
Proceeds from sales of investmen...
Atm offering, net of fees
Others
Negative Cash Flow Breakdown
Net loss
Purchases of investments
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-128,022
-158,325
-157,662
-90,787
Amortization of investment premiums
885
1,293
1,731
2,029
Amortization of financing costs
0
0
0
8
Stock-based compensation
11,133
10,337
8,587
7,336
Amortization of right-of-use assets
157
85
94
114
Realized gain on investments
30
-
41
10
Interest expense related to operating lease liability
111
1
-16
8
Prepaid expenses and other current assets
10,736
-4,628
-14,278
4,834
Accrued interest, net of interest receivable on maturity of investments
-120
-936
-413
-2,204
Accounts payable
1,830
13,931
48,838
-1,081
Accrued expenses
1,341
15,863
2,066
-4,802
Lease liability
-191
-139
-116
-130
Net cash used in operating activities
-125,172
-113,976
-85,290
-94,003
Purchases of investments
70,054
72,437
40,493
21,454
Proceeds from sales of investments
38,466
-
-
-
Proceeds from maturities of investments
141,019
126,626
116,105
181,479
Net cash provided by investing activities
109,431
54,189
75,612
160,025
Public offering, net of offering costs
-
-
0
0
Value of shares withheld related to employee tax withholding
-
-
0
0
Proceeds from warrant and option exercises and stock issuances under employee stock purchase plan
-
-
2,491
-
Proceeds from exercises of stock options and other stock issuances
1,013
-886
-
480
Atm offering, net of fees
22,573
11,627
73,948
0
Net cash provided by financing activities
23,586
12,077
75,103
480
Net (decrease) increase in cash, cash equivalents and restricted cash
7,845
-47,710
65,425
66,502
Cash, cash equivalents and restricted cash beginning of period
118,116
165,810
37,940
37,940
Effect of exchange rate changes on cash
0
16
9
-6
Cash, cash equivalents and restricted cash at end of period
125,961
118,116
165,810
100,376
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of investments
$141,019K
(-15.04%↓ Y/Y)
Atm offering, net of
fees
$22,573K
Proceeds from exercises
of stock options...
$1,013K
(99.80%↑ Y/Y)
Proceeds from sales of
investments
$38,466K
Net cash provided by
investing activities
$109,431K
(157.45%↑ Y/Y)
Net cash provided by
financing activities
$23,586K
(4552.07%↑ Y/Y)
Canceled cashflow
$70,054K
Net (decrease)
increase in cash, cash...
$7,845K
(293.80%↑ Y/Y)
Canceled cashflow
$125,172K
Purchases of investments
$70,054K
(-43.27%↓ Y/Y)
Stock-based compensation
$11,133K
(-17.82%↓ Y/Y)
Accounts payable
$1,830K
(182.84%↑ Y/Y)
Accrued expenses
$1,341K
(-90.84%↓ Y/Y)
Amortization of right-of-use
assets
$157K
(40.18%↑ Y/Y)
Accrued interest, net of
interest receivable on...
-$120K
(-1190.91%↓ Y/Y)
Interest expense related
to operating lease...
$111K
(1287.50%↑ Y/Y)
Net cash used in
operating activities
-$125,172K
(-165.98%↓ Y/Y)
Canceled cashflow
$14,692K
Net loss
-$128,022K
(-95.27%↓ Y/Y)
Prepaid expenses and
other current assets
$10,736K
(110.96%↑ Y/Y)
Amortization of investment
premiums
$885K
(-62.99%↓ Y/Y)
Lease liability
-$191K
(-46.92%↓ Y/Y)
Realized gain on
investments
$30K
(650.00%↑ Y/Y)
Buy us a coffee
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)